ARS Pharmaceuticals, Inc. - Common Stock (NQ:SPRY)
Price and Volume
Detailed Quote| Volume | 2,133,680 |
| Open | 9.370 |
| Bid (Size) | 8.980 (1,000) |
| Ask (Size) | 9.030 (100) |
| Prev. Close | 9.400 |
| Today's Range | 9.020 - 9.600 |
| 52wk Range | 6.660 - 18.90 |
| Shares Outstanding | 95,568,307 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Earnings Outlook For ARS Pharmaceuticals ↗
November 07, 2025
Earnings Outlook For ARS Pharmaceuticals ↗
August 12, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 03, 2025
ARS Pharma Sales Jump 3,040% in Q2 ↗
August 13, 2025
Earnings Scheduled For August 13, 2025 ↗
August 13, 2025
Frequently Asked Questions
Is ARS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ARS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ARS Pharmaceuticals, Inc. - Common Stock trade on?
ARS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ARS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ARS Pharmaceuticals, Inc. - Common Stock is SPRY on the Nasdaq Stock Market
What is the current price of ARS Pharmaceuticals, Inc. - Common Stock?
The current price of ARS Pharmaceuticals, Inc. - Common Stock is 9.040
When was ARS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ARS Pharmaceuticals, Inc. - Common Stock was at 12/02/25 04:00 PM ET
What is the market capitalization of ARS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ARS Pharmaceuticals, Inc. - Common Stock is 863.94M
How many shares of ARS Pharmaceuticals, Inc. - Common Stock are outstanding?
ARS Pharmaceuticals, Inc. - Common Stock has 864M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube